Skip to content
STRATUM

ETON

Eton Pharmaceuticals, Inc.
CIK 0001710340 · Pharmaceutical Preparations
Z″ LOWER ZONE
Z′ 0.14
Net margin
-5.8%
as of 2025-12-31
Operating margin
-1.1%
as of 2025-12-31
Revenue YoY growth
104.9%
as of 2025-12-31
Provenance: ETON’s most recent Revenue
$79,950,000
Filing
0001437749-26-009059 (10-K)
Period
2025-01-01 to 2025-12-31
XBRL tag
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Context
d_2025-01-01_2025-12-31
Mapping
seed · confidence 1.00
View the filed document ↗